Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis

Prostate cancer (PrC) is the second-most frequent cancer in men, its incidence is emerging globally and is the fifth leading cause of death worldwide. While diagnosis and prognosis of PrC have been studied well, the associated therapeutic biomarkers have not yet been investigated comprehensively. Th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2020-05, Vol.12 (5), p.1199
Hauptverfasser:	Jayaraj, Rama, Raymond, Greg, Krishnan, Sunil, Tzou, Katherine S, Baxi, Siddhartha, Ram, M Ravishankar, Govind, Suresh Kumar, Chandramoorthy, Harish C, Abu-Khzam, Faisal N, Shaw, Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgens Angiogenesis Bias Biomarkers Cancer therapies Case studies Cell proliferation Cell survival Chemoresistance Chemotherapy DNA methylation Drug development Drug resistance Meta-analysis MicroRNAs miRNA Oncology Paclitaxel Prostate cancer Quality control Stem cells Systematic review Therapeutic targets
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!